tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports

Kalaris Therapeutics (KLRS) Balance Sheet

374 Followers

Kalaris Therapeutics Balance Sheet

Kalaris Therapeutics's total assets for Q4 2025 were $121.74M, an increase of 49.97% from the previous quarter. KLRS total liabilities were $42.92M for the fiscal quarter, a 9.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 121.74M$ 118.55M$ 3.33M$ 3.90M$ 286.59M
Total Liabilities
$ 42.92M$ 5.24M$ 48.35M$ 34.17M$ 61.33M
Total Equity Gross Minority
$ 78.81M$ 113.31M$ -45.02M$ -30.27M$ 225.27M
Other Metrics
Currency in USD

Kalaris Therapeutics Debt to Assets